Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacologic therapy in the elderly].

C Pettenati

    Recenti Progressi in Medicina
    |June 21, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Older adults face higher risks of adverse drug reactions (ADR) due to polypharmacy and unique disease presentations. Careful pharmacological treatment is essential, yet data on elderly patients in clinical trials remain insufficient.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Retropubic tape surgery for stress urinary incontinence: can women be cured without voiding dysfunction?

    World journal of urology·2023
    Same author

    French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer.

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
    Same author

    Management of long ureteral stenosis: Alternatives to indwelling ureteral stents.

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2021
    Same author

    Nephron sparing surgery in tumours greater than 7cm.

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2018
    Same author

    [Not Available].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
    Same author

    [Not Available].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    See all related articles

    Area of Science:

    • Gerontology
    • Clinical Pharmacology
    • Pharmacoepidemiology

    Background:

    • Older adults are major drug consumers and highly susceptible to adverse drug reactions (ADR).
    • Polypharmacy significantly increases the frequency and severity of ADRs in the elderly population.
    • Inappropriate drug prescribing, including underuse of beneficial medications, is common.

    Discussion:

    • The atypical presentation of diseases in older individuals complicates pharmacotherapy optimization.
    • ADRs in the elderly can be misdiagnosed as new conditions, leading to further prescriptions.
    • Lack of robust clinical trial data for elderly populations, particularly frail individuals, hinders risk-benefit assessments.

    Key Insights:

    • Pharmacological treatment in older adults requires meticulous consideration due to heightened ADR risks.

    Related Experiment Videos

  • Optimizing drug regimens necessitates addressing polypharmacy and atypical disease manifestations.
  • Underutilization of effective treatments and misinterpretation of ADRs are critical issues.

    • Outlook:

    • Future research should prioritize the inclusion of diverse elderly populations in clinical trials.
    • Developing evidence-based guidelines for geriatric pharmacotherapy is crucial.
    • Enhanced monitoring and diagnostic strategies are needed to improve medication safety in older patients.